Effect of parenteral iron sucrose therapy to improve the feto-maternal prognosis related to iron deficiency anemia
Keywords:
Postpartum, Parenteral iron sucrose, Anemia, Hematological parametersAbstract
Background: The objective was to determine the effect of parenteral iron sucrose therapy to improve the feto-maternal prognosis related to iron deficiency anemia.
Methods: This was a longitudinal study conducted among 205 women admitted in a out-patient clinic of a tertiary care hospital and received iron sucrose. The iron sucrose dose was calculated from the following formula: weight before pregnancy (kg) -(110 g/L – actual hemoglobin [g/L]) X 0.24+ 500 mg. Treatment efficacy was assessed by measuring hemoglobin ferritin and other hematological parameters on the 30th day, at delivery and at first day of postpartum.
Results: Hemoglobin level was significantly (p<0.001) increased from baseline (8.33±1.13) to 30th (9.45±1.02), at delivery (11.89±0.89) and at first postpartum day (12.15±1.11). However, TIBC significantly (p=0.01) decreased from baseline to first postpartum day. Significant (p<0.0001) increase was also noted in serum ferritin and serum folate levels from baseline to 30th day, at delivery and at first postpartum day. MCV and MCH were significantly (p=0.01) increased from baseline to only at delivery and at first postpartum day. Percent change analysis showed that there was higher change in serum ferritin and serum folate levels than Hb, MCV and MCH levels. About one third (34%) of the patients did not complain any complications during supplementation.
Conclusion: With regard to the use of intravenous iron in obstetrics, there is increasing evidence that iron sucrose is safe for the mother and the fetus using the recommended dosages and therapy regimens.
Metrics
References
Van Wyck DB, Cavallo G, Spinowitz BS, Adhikarla R, Gagnon S, Charytan C, et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis 2000;36:88–97.
Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol 2004;76:74–8.
Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 1999;33: 464–70.
Dickason LA, Dinsmoor MJ. Red blood cell transfusion and cesarean section. Am J Obstet Gynecol 1992;167:327–30.
al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;69:121-4.
Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol, 2002;186:518–22.
Huch R, Breymann C. Anaemia in Pregnancy and Postpartum (ed 1). Bremen, Germany, Uni-Med Verlag, 2005.
Scot BS, George MR. Parental iron therapy option. Am J 2004:76:74-8.
Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidn Dis 2001;38:988-91.
Crichton R, Danielson B, Geisser P: Iron Therapy. Bremen, Germany, Uni-Med Verlag, 2005
Kumar A., Jain S., Singh N. P., and Singh T. Oral versus high dose parenteral iron supplementation in pregnancy. International Journal of Gynecology and Obstetrics, 2005;89(1):7–13.
Jacobs P., Johnson G., and Wood L. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. Journal of Medicine, 1984; vol. 15, no. 5-6, pp. 367–377.
Sharma N. Iron absorption: IPC therapy is superior to conventional iron salts. Obstetrics & Gynecology, 2001; pp. 515–519.
Lawrence R. and Helenek M. Development and comparison of iron dextran products. PDA Journal of Pharmaceutical Science and Technology, 1998; vol. 52, no. 5, pp. 190–197.
Auerbach M., Goodnough L. T., Picard D., and Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion, 2008; vol. 48, no. 5, pp. 988–1000.
Auerbach M. and Rodgers G. M. Intravenous iron. New England Journal of Medicine, 2007; vol. 357, no. 1, pp. 93–94.
Khalafallah A., Dennis A., Bates J. et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. Journal of Internal Medicine, 2010; vol. 268, no. 3, pp. 286–295.
Reveiz L., Gyte G. M., Cuervo L. G., and Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews, 2011; no. 10, Article ID CD003094.
Khalafallah A. and Mohamed M. Nutritional iron deficiency. in Anemia, In Tech, Rijeka, Croatia, 2012.
Pritchard JA. Hemoglobin regeneration in severe iron-deficiency anemia: response to orally and parenterally administered iron preparations. JAMA. 1966;195:717-20.
